Every SEC Form 3/4/5 on record for this filer (CIK 1682090) — 6 issuers, 12 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | 10% owner | 2020-09-17 → 2026-04-09 | 8 | — |
| UPB | Upstream Bio, Inc. | Director | 2024-10-10 → 2024-10-17 | 2 | — |
| GLTO | Galecto, Inc. | 10% owner · lapsed | 2020-10-28 → 2023-08-17 | 9 | $11M |
| ETNB | 89bio, Inc. | 10% owner · lapsed | 2019-11-08 → 2022-01-27 | 4 | — |
| LOGC | LogicBio Therapeutics, Inc. | Director · lapsed | 2018-10-18 → 2020-10-05 | 3 | $12M |
| STDY | SteadyMed Ltd. | 10% owner · lapsed | 2016-08-12 → 2018-09-07 | 3 | −$19M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| GLTO | 2020-11-02 | Buy | 209,500 | $15.00 | $3M | 1,031,811 |
| GLTO | 2020-11-02 | Buy | 523,833 | $15.00 | $8M | 2,579,657 |
| LOGC | 2018-10-23 | Buy | 490,000 | $10.00 | $5M | 5,766,783 |
| LOGC | 2018-10-23 | Buy | 700,000 | $10.00 | $7M | 6,466,783 |
2 of 6 issuers are covered and open a security page; the rest are on file here only.
